⌘K

Login Start Free

Home/Filings/5/0001593968-19-000408

5//SEC Filing

Glover Eddie Wabern 5

Accession 0001593968-19-000408

CIK 0000887247other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 6:44 PM ET

Size

4.6 KB

Accession

0001593968-19-000408

Insider Transaction Report

Form 5

Period: 2018-12-31

Adamis Pharmaceuticals CorpADMP

Glover Eddie Wabern

CEO of U.S. Compounding, Inc.

Transactions

Gift
Common Stock
2018-06-04−41,666→ 741,668 total

Documents

1 file

5
primary_01.xmlPrimary
PRIMARY DOCUMENT

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeother

Related Parties

1

filerCIK 0001671547

Filing Metadata

Form type: 5
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 6:44 PM ET
Size: 4.6 KB

View on SEC.gov